https://www.selleckchem.com/pr....oducts/dabrafenib-gs
Tricuspid regurgitation after mitral valve surgery is common and it may affect long-term survival and quality of life. The pathophysiology of this lesion after mitral valve surgery in patients without preoperative tricuspid regurgitation remains elusive in most cases. Correcting a tricuspid annulus of ≥ 40 mm by means of an annuloplasty at the time of mitral valve surgery in patients without tricuspid regurgitation has been proposed as a potential preventative measure but this value of annular dilatation has been challenge
Like
Comment
Share
